Article
20 Oct 2025
What To Watch: Human Cell And Tissue Product Regulation
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
08 Oct 2025
FDA Touts Continued Commitment To Cell And Gene Therapy Products Through Trio Of Guidances
Article
23 Sep 2025
FDA Unleashes Wave Of Enforcement: The Industry Faces A Crackdown On Drug Advertising
Article
07 Aug 2025
What To Watch: WHOOP Warning Letter
Article
03 Jul 2025
What's Going On With Human Cell And Tissue Products?
Article
23 Jun 2025
What To Watch: Potential Increase In Enforcement Of "RUO" Diagnostics
Article
10 Apr 2025
LDT Final Rule Series: Part 4 – Rule Overturned By Federal District Court
Article
10 Apr 2025
LDT Final Rule Series: Part 4 – Rule Overturned By Federal District Court
Article
12 Feb 2025
Finally, FDA's Final Word On Unapproved Use Communications
Article
03 Feb 2025
FDA Dumps Trio Of Device-Related Guidances Prior To Administration Change
Article
17 Jan 2025
FDA Furthers Efforts To Improve The Accelerated Approval Pathway Through New Draft Guidance On Confirmatory Trials
Article
27 Dec 2024
New Accelerated Approval Guidance Underscores Need For Accountability
Article
19 Dec 2024
LDT Final Rule Series: Part 3 – Legal Challenges
Article
11 Dec 2024
FDA Releases Long-Anticipated Guidance On Predetermined Change Control Plans For Devices That Utilize AI/ML Software
Article
24 Sep 2024
The Future Of FDA Policy: Reflections From The Summer Of 'Chevron'
Article
10 Jun 2024
LDT Final Rule Series: Part 2 – Response To The Rule
Article
06 May 2024
FDA Makes Good On Its Promise To Regulate Laboratory-Developed Tests
Article
30 Apr 2024
FDA Warning Letter Regulates "Research Only" Labels
Article
18 Mar 2024
Oregon Prescription Drug Price Transparency Act In Limbo
Article
07 Feb 2024
OIG Permits Medical Device Manufacturer's Cost-Sharing Subsidies For Medicare Beneficiaries In Clinical Trial